Agilis Robotics is a Hong Kong-based surgical robotics startup committed to transforming endoluminal surgery with our highly miniaturized and flexible robotic instruments. Our mission is to eliminate the steep learning curve that is associated with traditional endoluminal surgery, which is hindered by cumbersome and unintuitive instruments. What sets us apart is that our robotic instruments are compatible with standard endoscopes used in clinical practice, allowing for seamless and cost-effective adoption into current clinical workflows. Additionally, our system is versatile and can be used for both flexible and rigid endoluminal surgeries in the GI tract and bladder, making it a unique value proposition in the current landscape of surgical robotics.

The surgical robotics market is rapidly growing, but current systems are expensive and unwieldy to implement, making it hard for smaller hospitals to adopt. Agilis Robotics’ solution fills this gap with a compact, cost-effective, and straightforward solution specifically targeting endoluminal surgery. With the growing trend towards accessible and easy-to-use solutions, Agilis Robotics is well-positioned to make a significant impact in the market. Our innovative technology has the potential to improve patient outcomes, reduce healthcare costs, and make surgical robotics more accessible to a wider range of healthcare providers.